₹1,571.1
▼ -8.21 -0.52%
18 Jul 2026
NSE Listed · Pharmaceuticals
Haleos Labs Limited (HALEOSLABS)
Volume: 425Avg Vol 1W: 505Avg Vol 1M: 69252W Range:₹1,067₹1,774
Key Ratios
Checked 11h agoMarket Cap₹481 Cr
Current Price₹1,571.1
Previous Close₹1,579.31
High / Low (52w)₹1,774 / ₹1,067
Volume425
Avg Vol (1W)505
Avg Vol (1M)692
Stock P/E27.78
Book Value₹706.33
Dividend Yield9%
ROE8.11%
ROA391.72%
Revenue (TTM)—
Revenue Growth12.67%
Profit Margin5.19%
Total Debt₹18 Cr
Shares Outstanding0 Cr
Face Value₹10
EPS (TTM)₹57.26
P/B2.25
Debt / Equity0.5
50 DMA₹1,507.48
200 DMA₹1,417.95
Day change-0.52%
Price Chart
₹1,571.1▲ 30.95% · 1Y
2025-10-312026-07-17
20-day avg volume: 598 shares
Pros
- Pays a dividend yield of 9.0%.
- Company is almost debt-free.
- Revenue grew 13% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹93 Cr | ₹78 Cr | ₹85 Cr | ₹89 Cr | ₹83 Cr | ₹81 Cr | ₹95 Cr | ₹75 Cr |
| EBITDA | ₹13 Cr | ₹7 Cr | ₹9 Cr | ₹6 Cr | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹2 Cr |
| Net Profit | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹6 Cr | ₹7 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹380 Cr | ₹263 Cr | ₹267 Cr | ₹352 Cr | ₹319 Cr | ₹310 Cr | ₹350 Cr |
| EBITDA | ₹31 Cr | ₹20 Cr | ₹24 Cr | ₹26 Cr | ₹21 Cr | ₹20 Cr | ₹35 Cr |
| Net Profit | ₹18 Cr | ₹10 Cr | ₹14 Cr | ₹25 Cr | ₹11 Cr | ₹9 Cr | ₹20 Cr |
| EPS | 59.03 | 33.68 | 44.84 | 83.76 | 37.92 | 30.08 | 66.51 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹270 Cr | ₹253 Cr | ₹302 Cr | ₹357 Cr | ₹395 Cr | ₹391 Cr | ₹390 Cr |
| Total Liabilities | ₹164 Cr | ₹137 Cr | ₹173 Cr | ₹192 Cr | ₹207 Cr | ₹198 Cr | ₹178 Cr |
| Equity | ₹106 Cr | ₹116 Cr | ₹129 Cr | ₹165 Cr | ₹188 Cr | ₹194 Cr | ₹212 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Operating | ₹37 Cr | ₹18 Cr | ₹40 Cr | ₹-4 Cr | ₹18 Cr | ₹27 Cr | ₹43 Cr |
| Investing | ₹-44 Cr | ₹-27 Cr | ₹-26 Cr | ₹-7 Cr | ₹-31 Cr | ₹-18 Cr | ₹-15 Cr |
| Financing | ₹15 Cr | ₹12 Cr | ₹-3 Cr | ₹11 Cr | ₹17 Cr | ₹-7 Cr | ₹-19 Cr |
| Free Cash Flow | ₹37 Cr | ₹18 Cr | ₹40 Cr | ₹-4 Cr | ₹18 Cr | ₹27 Cr | ₹43 Cr |
Shareholding
Promoter 72.11% Institutions 0.31% Public 27.58%
Efficiency & Working Capital
ROCE9.8%
Interest Coverage4
Dividend Payout—
Debtor Days65 d
Inventory Days64 d
Payable Days50 d
Cash Conversion Cycle78 d
Working Capital Days129 d
Shareholding Details
As of 2026-06-30
Promoter72.1%
FII0%
DII0.3%
Institutions0.3%
Public27.6%
Promoter Pledge0%
No. of Shareholders6,859
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.3% | 70.7% | 71.2% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.4% | 71.8% | 72.1% | 72.1% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.3% | 0.3% | 0.3% |
| Public | 29.7% | 29.3% | 28.8% | 28.6% | 28.6% | 28.6% | 28.6% | 28.6% | 28.6% | 27.9% | 27.6% | 27.6% |
| Promoter Pledge | 3.4% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 8,443 | 8,233 | 8,116 | 7,861 | 7,849 | 7,626 | 7,479 | 7,412 | 7,521 | 7,125 | 6,937 | 6,859 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Annapurna Talluri | Shareholding of Promoter and Promoter Group | 24.6% | 7,42,436 |
| Tvvsn Murthy | Shareholding of Promoter and Promoter Group | 15.9% | 4,80,034 |
| Venkata Praveen Talluri | Shareholding of Promoter and Promoter Group | 9.1% | 2,73,939 |
| Ramesh Babu Potluri | Shareholding of Promoter and Promoter Group | 7.9% | 2,40,190 |
| Sudeepthi Gopineedi | Shareholding of Promoter and Promoter Group | 6.6% | 1,99,494 |
| Hima Bindu Potluri | Shareholding of Promoter and Promoter Group | 2.8% | 83,333 |
| Trilok Potluri | Shareholding of Promoter and Promoter Group | 2.6% | 78,141 |
| Vamsi Krishna Potluri | Shareholding of Promoter and Promoter Group | 2.4% | 73,234 |
| Harita Projects Private | Public Shareholding | 1.8% | 53,087 |
| S Vijayakumar | Public Shareholding | 1.1% | 33,615 |
| Potluri Infra Projects Llp | Shareholding of Promoter and Promoter Group | 0.3% | 8,000 |
| Sukumari Koneru | Shareholding of Promoter and Promoter Group | 0% | 714 |
| Venkata Chaitanya Gopineedi | Shareholding of Promoter and Promoter Group | 0% | 361 |
| Tvvsn Murthy (huf) (karta - Mr.tvvsn Murthy) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rajeswara Rao Gopineedi | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Potluri Laboratories Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pixalot Labs Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Tvvsn Murthy (huf) (karta - Mr.tvvsn Murthy) | 0 | 0% | 2026-06-30 |
| Hima Bindu Potluri | 0 | 0% | 2026-06-30 |
| Annapurna Talluri | 0 | 0% | 2026-06-30 |
| Tvvsn Murthy | 0 | 0% | 2026-06-30 |
| Rajeswara Rao Gopineedi | 0 | 0% | 2026-06-30 |
| Venkata Praveen Talluri | 0 | 0% | 2026-06-30 |
| Ramesh Babu Potluri | 0 | 0% | 2026-06-30 |
| Sudeepthi Gopineedi | 0 | 0% | 2026-06-30 |
| Venkata Chaitanya Gopineedi | 0 | 0% | 2026-06-30 |
| Sukumari Koneru | 0 | 0% | 2026-06-30 |
| Vamsi Krishna Potluri | 0 | 0% | 2026-06-30 |
| Trilok Potluri | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| T V V S N Murthy | ED / MD / Promoter | 2025 |
| Talluri Venkata Praveen | Executive Director | 2025 |
| Sudeepthi Gopineedi | WTD & Executive Director | 2025 |
| P Sarath Kumar | Independent Non Exe. Director | 2025 |
| Mannam Malakondaiah | Independent Non Exe. Director | 2025 |
| Srinivas Samavedam | Independent Non Exe. Director | 2025 |
| Sundaramma Patibandla | Independent Non Exe. Director | 2025 |
| Trupti Ranjan Mohanty | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuical Products | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Exports | ₹131 Cr | 39.3% |
| Deemed Exports | ₹7 Cr | 2% |
| Domestic | ₹195 Cr | 58.5% |
| Export Incentive | ₹1 Cr | 0.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 4 | 3 | 3 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-24 | ₹1.5 (15%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 4 | 79 | 83 |
| 2025 | 0 | 0 | 0 | 4 | 48 | 52 |
| 2025 | 0 | 0 | 0 | 0 | 31 | 31 |
Insider / Designated-Person Trades
29 recent disclosure(s)
TV PRAVEENAcquisition · 9,400
TV PRAVEENAcquisition · 1,787
TV PRAVEENAcquisition · 10,000
TV PRAVEENAcquisition · 1,20,595
Sudeepthi GopineediAcquisition · 1,20,595
TVVSN Murthy HUFDisposal · 2,41,190
Substantial Acquisitions (SAST)
11 disclosure(s)
Market26/12/2025 · 1,787
Market24/12/2025 · 10,000
Inter-se Transfer18/03/2025 · 2,41,190
Inter-se Transfer18/03/2025 · 1,20,595
Inter-se Transfer18/03/2025 · 1,20,595
Market27/06/2024 - 28/06/2024 · 6,367
Company Information
🌐 www.smslife.in ↗
📍 Plot No 19-III Road No 71, Opp Bharatiya Vidya Bhavan PSc, Hyderabad, Telangana, 500096
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search